These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10897845)

  • 1. [Anatomopathological tools for screening and medical surveillance of people exposed to asbestos].
    Galateau-Salle F
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1244-56. PubMed ID: 10897845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Social impact of screening and of medical surveillance on people exposed to asbestos].
    Bergeret A; Terrasson De Fougères G
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1327-31. PubMed ID: 10897854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical impact of screening of benign pleural lesions associated with the inhalation of asbestos dust].
    Chailleux E; Letourneux M
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1286-93. PubMed ID: 10897850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic examinations of former workers of asbestos processing plants: the Amiantus project].
    Szeszenia-Dabrowska N; Szubert Z
    Med Pr; 2002; 53(6):451-6. PubMed ID: 12701534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000-2004].
    Szubert Z; Stankiewicz-Choroszucha B; Wrońska-Sobolewska M; Siewierska H; Kosińska M; Borys W; Jakubowski J; Wróbel R; Gazda U; Kedzierska B; Andrzejewski M; Sova M; Pawłowska-Koziełł H; Komorowska E; Ksiazkiewicz B; Sobala W; Szeszenia-Dabrowska N
    Med Pr; 2006; 57(2):101-8. PubMed ID: 16871953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in risk assessment of asbestos exposure.
    Bhattacharya K; Dopp E; Kakkar P; Jaffery FN; Schiffmann D; Jaurand MC; Rahman I; Rahman Q
    Mutat Res; 2005 Nov; 579(1-2):6-21. PubMed ID: 16112146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical impact of screening of broncho-pulmonary cancer in subjects exposed to asbestos].
    Milleron B; Depierre A; Paris C
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1308-16. PubMed ID: 10897852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of diseases associated with asbestos. On-going activities, synthesis].
    Frimat P; Paris C; Letourneux M; Catilina P; Sobaszek A
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1350-5. PubMed ID: 10897856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk assessment of benign asbestosis (dose-effect relationship, time-effect relationship, co-factors)].
    Letourneux M
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1270-7. PubMed ID: 10897848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exposure to asbestos: role of respiratory function tests as tools for screening and follow-up].
    Perdrix A; Yernault JC
    Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1203-11. PubMed ID: 10897841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical surveillance of workers previously exposed to asbestos.
    Cristaudo A; Foddis R; Buselli R; Gattini V; Di Palma N; Guglielmi G
    Med Lav; 2006; 97(3):475-81. PubMed ID: 17009683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological findings of pre-invasive bronchial lesions detected by light-induced fluorescence endoscopy in a lung cancer screening system.
    Baba M; Iyoda A; Nomoto Y; Shibuya K; Hiroshima K; Saito H; Taguchi A; Kounoike K; Saegusa F; Kuwahara T; Tsujii H; Fujisawa T
    Oncol Rep; 2007 Mar; 17(3):579-83. PubMed ID: 17273736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asbestos-related lung disease.
    O'Reilly KM; Mclaughlin AM; Beckett WS; Sime PJ
    Am Fam Physician; 2007 Mar; 75(5):683-8. PubMed ID: 17375514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
    Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for asbestos-related conditions].
    Brauer C; Baandrup U; Jacobsen P; Krasnik M; Olsen JH; Pedersen JH; Rasmussen TR; Schlünssen V; Sherson D; Svolgaard B; Sørensen JB; Omland O
    Ugeskr Laeger; 2009 Feb; 171(6):433-6. PubMed ID: 19208334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of asbestosis.
    Kuku O; Parker DL
    Minn Med; 2000 Nov; 83(11):47-9. PubMed ID: 11126482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant mesothelioma of the pleura among women].
    Bianchi C; Bianchi T; Ramani L
    Med Lav; 2004; 95(5):376-80. PubMed ID: 15595200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are lung and pleural benign asbestos induced diseases a preliminary step in the pathogenic process of mesothelioma and lung cancer development?
    Goldberg M
    Occup Environ Med; 2005 Oct; 62(10):663-4. PubMed ID: 16169909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.